Mingyuan Medicare Development Co., Ltd. Stock

Mingyuan Medicare Development Company Limited is a Hong Kong-based investment holding company principally engaged in the provision of healthcare solutions. The Company operates through five divisions. Protein Chips division is engaged in the manufacture and distribution of C-12 products. Health Care division is engaged in the sales and marketing of cervical diseases-related products. Medical Centers Management division is engaged in the provision of healthcare services. Individualized Target Therapy division is engaged in the development of specialized molecular diagnostic kits for leukemia, lymphoma and individualized target cancer therapy. Bio-drugs division is engaged in the development and production of a new generation of non-specific nanotechnology immunomodulatory drugs.